Need to get your DEA licensure training? Look to Continuum.
February 7, 2025
Continuum: Lifelong Learning in Neurology®, the AAN’s official CME journal, now offers Drug Enforcement Administration (DEA) licensure training—a requirement for clinicians who prescribe controlled substances.
The Medication Access and Training Expansion (MATE) Act requires new or renewing DEA licensees to complete a total of eight hours of accredited training on opioid or other substance use disorders and the appropriate treatment of pain. In the new course, licensees fulfill the requirement by reading a curated set of in-depth Continuum® articles, taking a 27-question postreading test, and completing an evaluation.
“There are two important benefits of this course,” said Lyell K. Jones, Jr., MD, FAAN, the journal’s editor-in-chief. "First, it’s more relevant for neurology professionals—it provides specific, clinically useful information for our practice that isn’t included in the more general content we’ve seen in other courses. Second, subscribers can simply find the course in the AAN’s online learning center and complete it at their convenience.”
Continuum offers six issues per year, each based around a single topic area in neurology and written by expert authors—meaning subscribers have access to a continually updated “living” record of the latest in neurology, relevant for any career stage. Subscriptions are free for Junior AAN members and for other members.
Along with the new online DEA course, Continuum subscriptions include print, online, and audio versions of each issue, access to the online archives, and the opportunity to earn up to 20 AMA PRA Category 1 Credits™ of self-assessment CME per issue. Continuum® Audio, a free podcast featuring interviews with the publication’s expert authors and editors, is also available on your favorite podcast platform.
Logged-in subscribers can take the .